Novartis’s Alcon cares project 100 commits to reducing cataract blindness globally
Alcon, a division of Novartis, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America,…
Pharmaceuticals, Biotechnology and Life Sciences
Alcon, a division of Novartis, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America,…
LEH Pharma, the provider of novel ocular implants for macular disorders, has appointed Sir Henry Riley as Chairman of the…
Hikma Pharmaceuticals’s US subsidiary West-Ward Pharmaceuticals has launched Methotrexate for Injection, USP in a 1g preservative-free presentation and Methotrexate Injection,…
Concepta has signed an agreement with SinoPharm, the largest state-owned pharmaceutical company in China, with annual sales of over £23…
Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow…
AstraZeneca and MedImmune, its global biologics research and development arm, brought to public high-level results from the Phase III ARCTIC…
Sanofi’s Head of Global Research and Development, Elias Zerhouni, will retire from the company after more than 9 years, in the…
Eli Lilly and Incyte Corporation scored a recommended approval of the 2-mg dose of a once-daily oral medication baricitinib from…
Beximco Pharmaceuticals has begin the export Methocarbamol tablets to the US, generic equivalent to Auxilium Pharmaceuticals’ muscle relaxant Robaxin tablets, 500mg…
Hikma Pharmaceuticals has launched Dexrazoxane for Injection, 250mg and 500mg vials, the generic equivalent to Zinecard, through its US wholly-owned subsidiary…